Patricia Conrod, PhD

Special Seminar
Mercredi, 6. Novembre 2019 - 15:00
Patricia Conrod

 

Please join us on November 6, at 3 pm in the Bowerman Room (Dobell Pavillion) for a talk by Patricia Conrod, PhD, entitled, "Targeting neurocognitive risk factors in early intervention and prevention of psychiatric conditions: A novel transdiagnostic approach".

Dr. Conrod is a Clinical Psychologist by training and a Full Professor of Psychiatry at the Université de Montréal. She is based at the CHU Sainte-Justine Mother and Child Hospital Research Centre in Montreal, where she holds a Tier 1 Canada Research Chair in Preventative Mental Health and Addiction, and a Research Chair in Social and Community Pediatrics funded by Fondation Julien/Jean & Marcelle Coutu. Her research focuses on cognitive, personality and biological risk factors for the development and maintenance of drug abuse and the factors that mediate the co-occurrence of addictive behaviours with other mental disorders. More recently, her research findings have led to the development of new approaches to substance abuse treatment and prevention that target personality risk factors and the underlying motivational determinants of drug use in subtypes of substance misusers. She developed the Preventure Program, which has been identified as an evidence-based prevention program in the UNODC International Standards for Drug Prevention and the U.S. Surgeon General’s 2016 Report on Addiction. Her research is funded by Canadian Institutes of Health Research, Fondation de Recherche en Santé du Quebec, European Commission (Health and Humanities and Social Sciences), National Institutes of Health, Medical Research Council-UK, National Health and Medical Research Council – Australia. She is a member of the CIHR Institute of Neurosciences Mental Health and Addiction Advisory Board, American College of Neuropsychopharmacology and Associate Editor of the Canadian Journal of Psychiatry. She has co-authored more than 200 peer reviewed articles, some of which published in Science, Nature, JAMA-Psychiatry, and American Journal of Psychiatry. Her research has also been featured in news articles in the Financial Times, New York Times, The Guardian, Time Magazine, Maclean’s Magazine and CNN. From 2016-2018, she participated as an advisor and spokesperson for Health Canada’s Public Education Campaign during the transition to cannabis legalisation and continues to train communities around the world on evidence-based drug and alcohol prevention strategies.

 

Location: 
Douglas Institute
Room: 
Bowerman Room, Dobell Pavilion